American pharmaceutical giant Merck revealed in its financial results announcement for the second quarter of 2017 that a recent cyberattack has disrupted its worldwide operations, including manufacturing, research and sales.
While Merck has not provided details about the incident in its financial report, the June 27 attack referenced by the company is most likely the NotPetya malware outbreak that affected tens of thousands of systems in more than 65 countries. Many of the victims were located in Ukraine, the home of a tax software firm whose product was used as the main attack vector.
